SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-20-269780
Filing Date
2020-10-15
Accepted
2020-10-15 07:05:59
Documents
6
Effectiveness Date
2020-10-15

Document Format Files

Seq Description Document Type Size
1 DEFA14A d34789ddefa14a.htm DEFA14A 41682
2 GRAPHIC g34789g001.jpg GRAPHIC 2648
3 GRAPHIC g34789g002.jpg GRAPHIC 1527
4 GRAPHIC g34789g003.jpg GRAPHIC 1529
5 GRAPHIC g34789g004.jpg GRAPHIC 1519
6 GRAPHIC g34789g005.jpg GRAPHIC 1530
  Complete submission text file 0001193125-20-269780.txt   55398
Mailing Address 320 WAKARA WAY SALT LAKE CITY UT 84108
Business Address 320 WAKARA WAY SALT LAKE CITY UT 84108 801-584-3600
MYRIAD GENETICS INC (Filer) CIK: 0000899923 (see all company filings)

IRS No.: 870494517 | State of Incorp.: DE | Fiscal Year End: 0630
Type: DEFA14A | Act: 34 | File No.: 000-26642 | Film No.: 201240305
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
Office of Life Sciences